Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (201-210 of 939) with videos related to

Pageof 94
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2020
An engineered 4-1BBL fusion protein with "activity on demand"Jacqueline Mock, Marco Stringhini, Alessandra Villa, et al.
Brain Pathology (Zurich, Switzerland)|December 6, 2003
P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cellsOliver Bähr, Johannes Rieger, Frank Duffner, et al.
Journal of Neuro-Oncology|March 16, 2004
MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma modelUlrich Herrlinger, Steffen Aulwurm, Herwig Strik, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 19, 2009
Lysosomal ceramide mediates gemcitabine-induced death of glioma cellsClaudia A Dumitru, Ibrahim E Sandalcioglu, Marek Wagner, et al.
Onkologie|August 1, 2012
Antiangiogenic treatment for multiple CNS hemangioblastomasChristian Riklin, Katharina Seystahl, Silvia Hofer, et al.
ESMO Open|July 13, 2019
How we treat glioblastomaMichael Weller, Emilie Le Rhun, Matthias Preusser, et al.
Cell Death & Disease|December 15, 2017
Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastomaEleanna Papa, Michael Weller, Tobias Weiss, et al.
Cancer Research|April 19, 2007
Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1Patrick Roth, Michel Mittelbronn, Wolfgang Wick, et al.
Neuro-Oncology|May 6, 2017
Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastomaManuela Silginer, Sara Nagy, Caroline Happold, et al.
Antibodies (Basel, Switzerland)|March 24, 2022
Design and Characterization of Novel Antibody-Cytokine Fusion Proteins Based on Interleukin-21Cesare Di Nitto, Dario Neri, Tobias Weiss, et al.
Pageof 94

Showing results (201-210 of 939) with videos related to

Sort By:
Pageof 94
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2020
An engineered 4-1BBL fusion protein with "activity on demand"Jacqueline Mock, Marco Stringhini, Alessandra Villa, et al.
Brain Pathology (Zurich, Switzerland)|December 6, 2003
P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cellsOliver Bähr, Johannes Rieger, Frank Duffner, et al.
Journal of Neuro-Oncology|March 16, 2004
MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma modelUlrich Herrlinger, Steffen Aulwurm, Herwig Strik, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 19, 2009
Lysosomal ceramide mediates gemcitabine-induced death of glioma cellsClaudia A Dumitru, Ibrahim E Sandalcioglu, Marek Wagner, et al.
Onkologie|August 1, 2012
Antiangiogenic treatment for multiple CNS hemangioblastomasChristian Riklin, Katharina Seystahl, Silvia Hofer, et al.
ESMO Open|July 13, 2019
How we treat glioblastomaMichael Weller, Emilie Le Rhun, Matthias Preusser, et al.
Cell Death & Disease|December 15, 2017
Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastomaEleanna Papa, Michael Weller, Tobias Weiss, et al.
Cancer Research|April 19, 2007
Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1Patrick Roth, Michel Mittelbronn, Wolfgang Wick, et al.
Neuro-Oncology|May 6, 2017
Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastomaManuela Silginer, Sara Nagy, Caroline Happold, et al.
Antibodies (Basel, Switzerland)|March 24, 2022
Design and Characterization of Novel Antibody-Cytokine Fusion Proteins Based on Interleukin-21Cesare Di Nitto, Dario Neri, Tobias Weiss, et al.
Pageof 94